Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 195Other hematologic neoplasm 149Plasma cell 101Sarcoma 57Myeloid 40CNS 40Gynecologic 36Thoracic 32Dermatologic 28Head & Neck 22Genitourinary 21Gastrointestinal 16Breast 14Classical hematology 12Other solid neoplasm 2Other neoplasm 2Endocrine 2Other 1NET 1

Conditions

Neuroendocrine Tumors 102Carcinoid Tumor 22Neoplasms 16Neoplasm Metastasis 10Gastro-enteropancreatic neuroendocrine tumor 10Carcinoma, Neuroendocrine 9Adenoma, Islet Cell 9Pancreatic Neoplasms 7Carcinoma 7Pheochromocytoma 6Paraganglioma 6Neuroblastoma 6Colorectal Neoplasms 6Carcinoma, Islet Cell 6Somatostatinoma 5Gastrointestinal Neoplasms 5Vipoma 4Small Cell Lung Carcinoma 4Serotonin Syndrome 4Neuroectodermal Tumors, Primitive 4Melanoma 4Medulloblastoma 4Lung Neoplasms 4Intestinal Neoplasms 4Gastrinoma 4Carcinoma, Non-Small-Cell Lung 4Adenocarcinoma 4Prostatic Neoplasms 3Neuroectodermal Tumors 3Neoplasms, Nerve Tissue 3

Interventions

entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Recurrence × NET × Clear all
NCT03211988 2026-03-02

Entinostat Neuroendocrine (NE) Tumor

Columbia University

Phase 2 Terminated
5 enrolled 9 charts
EndocrineNET

Recurrence, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡